Cancer Medicines Forum: June 2022
Table of contents
The EMA's Cancer Medicines Forum (CMF) aims to explore how EMA can contribute towards addressing remaining uncertainties about the use of cancer medicines in clinical practice.
The forum brings together representatives of academic organisations from EMA’s Healthcare Professionals Working Party and the European medicines regulatory network.
The results of discussions will support the prioritisation of actions to fight cancer in EMA's Regulatory Science Strategy to 2025 and Academia Collaboration Matrix Action Plan.
The meetings of the forum are by invitation only.
EMA launched the CMF together with the European Organisation for Research and Treatment of Cancer (EORTC) in March 2022.
EMA will review the composition and procedures of the forum after a one-year pilot phase.
-
List item
Minutes of the Cancer Medicines Forum - 28 June 2022 (PDF/112.46 KB)
First published: 03/11/2022
Last updated: 24/03/2023 -
List item
Presentation - Determining treatment value in haemato-oncology – opportunities and challenges (European Hematology Association) (PDF/941.81 KB)
First published: 24/03/2023 -
List item
Presentation - Current HTA Experience with Real World Data (B. Wieseler) (PDF/1.04 MB)
First published: 24/03/2023